Trials / Conditions / Stage IV Merkel Cell Carcinoma
Stage IV Merkel Cell Carcinoma
5 registered clinical trials studyying Stage IV Merkel Cell Carcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer NCT04670445 | Massachusetts General Hospital | N/A |
| Withdrawn | Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine NCT02831179 | Vanderbilt-Ingram Cancer Center | Phase 1 |
| Terminated | QUILT-3.009: Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC) NCT02465957 | ImmunityBio, Inc. | Phase 2 |
| Terminated | Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell Carcinoma NCT01758458 | Fred Hutchinson Cancer Center | Phase 1 / Phase 2 |
| Completed | Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade N NCT01204476 | National Cancer Institute (NCI) | Phase 1 |